NCT02732730 - Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study | Biotech Hunter

Enrollment

451

Participants

Timeline

Start Date

October 12, 2016

Primary Completion Date

October 25, 2018

Study Completion Date

October 25, 2018

Conditions

HIV

Interventions

DRUG

Truvada

400 women who accept to initiate PrEP

BEHAVIORAL

Drug level counseling at Weeks 8 and 13

Women who are randomized to enhanced counselling will have adherence monitoring based on plasma TFV levels obtained 4 and 8 weeks after PrEP acceptance

Trial Locations (3)

306

Spilhaus CRS, Harare

2001

Wits Reproductive Health and HIV Institute, Johannesburg

7750

Emavundleni CRS, Cape Town